Sarepta Therapeutics, Inc. (SRPT) insider trading

By person

16 insiders · 6 transactions

13.5×

Douglas S. Ingram holds 13.5 times base salary in stock. $15.82M of shares against $1.17M in salary for 2025.

Salary from the company's own proxy. The shares are what Douglas S. Ingram last reported holding, valued at $17.02, the price Common Stock was last bought or sold at on the open market here, on 12 Mar 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Ian Michael Estepan

Chief Operating Officer

—

$294.20K (1)

−$294.20K

177,184

0.1677%

$3.02M

+422.0%

Stephen Mayo

Director

—

$123.21K (1)

−$123.21K

18,640

0.0176%

$317.25K

+181.5%

Richard Barry

Director

—

2,983,542

2.82%

$50.78M

+1.8%

Douglas S Ingram

Chief Executive Officer

—

929,391

0.8799%

$15.82M

+138.1%

Michael Severino

Chief Executive Officer

—

756,104

0.7158%

$12.87M

—

M Kathleen Behrens

Director

—

214,357

0.2029%

$3.65M

+12.2%

Louise Rodino-Klapac

President, R&D and Tech Ops

—

203,900

0.1930%

$3.47M

+181.6%

Ryan Ho-Yan Wong

Chief Financial Officer

—

121,792

0.1153%

$2.07M

+589.8%

Cristin Rothfuss

EVP, General Counsel

—

115,519

0.1094%

$1.97M

+738.4%

Claude Nicaise

Director

—

48,407

0.0458%

$823.89K

+166.4%

Hans Lennart Rudolf Wigzell

Director

—

42,098

0.0399%

$716.51K

+84.3%

Dallan Murray

Chief Customer Officer

—

38,202

0.0362%

$650.20K

+71.9%

Bilal Arif

Chief Tech Ops Officer

—

32,500

0.0308%

$553.15K

+85.6%

Michael Andrew Chambers

Director

—

27,535

0.0261%

$468.65K

+232.7%

Kathryn Jean Boor

Director

—

25,138

0.0238%

$427.85K

+234.5%

Deirdre P Connelly

Director

—

22,100

0.0209%

$376.14K

+677.6%

Sarepta Therapeutics, Inc.

What the insiders did Net selling

By person